Brief: Champions Oncology announces strategic collaboration with AstraZeneca to develop unique cohorts of PDX models

Champions Oncology

21/08/2017 13:30

Aug 21 (Reuters) - Champions Biotechnology  Inc  CSBR.O  
    * Champions Oncology announces strategic collaboration with 
AstraZeneca to develop unique cohorts of patient-derived 
xenograft (PDX) models 
    * Champions Biotechnology  Inc- cohorts of PDX models will 
be used in AstraZeneca's Oncology research and development 
programs in breast and lung cancer 
 
Source text for Eikon:  ID:nPn6NkQd9a  
Further company coverage:  CSBR.O  
 
 (((Bangalore.newsroom@thomsonreuters.com;);))